JD Health International Inc. (HKG:6618)
60.20
+0.05 (0.08%)
At close: Dec 5, 2025
JD Health International Revenue
JD Health International had revenue of 35.29B CNY in the half year ending June 30, 2025, with 30.17% growth. This brings the company's revenue in the last twelve months to 65.11B, up 18.89% year-over-year. In the year 2024, JD Health International had annual revenue of 58.16B with 8.65% growth.
Revenue (ttm)
65.11B CNY
Revenue Growth
+18.89%
P/S Ratio
2.70
Revenue / Employee
18.27M CNY
Employees
3,564
Market Cap
192.73B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 38.69B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
| CSPC Pharmaceutical Group | 28.65B |